Armin Spura, PhD, CEO of BioDuro, talks concerning the firm’s evolution into a totally built-in contract, analysis, and growth manufacturing group (CRDMO), providing seamless companies throughout discovery to growth and commercialization. Spura discusses latest expansions in commercial-scale API manufacturing, peptide scale-up, and high-potency capabilities on the firm’s Bengbu, China location.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
